Elligo Health Research vs ConcertAI
Side-by-side comparison of AI visibility scores, market position, and capabilities
Clinical Trial Enablement & Patient Recruitment
Elligo Health Research brings clinical trials into healthcare settings by using EHR data for patient identification and providing site infrastructure; enables physicians to conduct trials without becoming dedicated research sites;
About
Elligo Health Research is a clinical research organization (CRO) and technology company founded in 2016 and headquartered in Austin, Texas, that embeds clinical trials within existing healthcare environments rather than requiring dedicated research centers. The company's model enables practicing physicians and health systems to conduct clinical trials for their own patients by providing the infrastructure, personnel, regulatory expertise, and data integration needed to run trials — without requiring those providers to become stand-alone research sites. This "research-in-care" approach significantly broadens the pool of potential trial sites and patients.
ConcertAI is an oncology AI and real-world data company at a $1.9B valuation — 5.5M multi-modal cancer RWD records, $230M+ raised, exiting FY2024 profitable with mid-teens EBITDA margins.
About
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates multi-modal patient data — including electronic health records, genomics, imaging, and pathology — from a network of oncology providers to support biopharma companies in clinical trial design, site selection, protocol optimization, patient matching, and regulatory submission.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.